doxazosin has been researched along with Cancer of Ovary in 1 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxazosin is an α1 adrenergic receptor blocker that also exerts antitumor effects." | 1.40 | The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression. ( Dong, SM; Kim, BR; Kim, DY; Lee, SH; Park, MS; Rho, SB, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, MS | 1 |
| Kim, BR | 1 |
| Dong, SM | 1 |
| Lee, SH | 1 |
| Kim, DY | 1 |
| Rho, SB | 1 |
1 other study available for doxazosin and Cancer of Ovary
| Article | Year |
|---|---|
The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Antihypertensive Agents; Blotting, Western; Cell L | 2014 |